Solid forms of ingenol 3-(3,5-diethylisoxazole-4-carboxylate) and method for preparing the same

US2019210980A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2019210980-A1
Application numberUS-201716330909-A
CountryUS
Kind codeA1
Filing dateAug 29, 2017
Priority dateSep 6, 2016
Publication dateJul 11, 2019
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are solid forms of ingenol 3-(3,5-diethylisoxazole-4-carboxylate) selected from an amorphous form or a crystalline anhydrous form. Also disclosed are solid solvates of ingenol 3-(3,5-diethylisoxazole-4-carboxylate) selected from an acetone solvate, a dimethylcarbonate solvate, an isopropyl ether solvate, an acetonitrile solvate, a toluene solvate, a mesitylene solvate, a nitromethane solvate, a dichloromethane/heptane solvate and an ethyl acetate solvate, for use as intermediates.

First claim

Opening claim text (preview).

1 . Solid forms of ingenol 3-(3,5-diethylisoxazole-4-carboxylate) selected from an amorphous form or a crystalline anhydrous form. 2 . The amorphous solid form of claim 1 characterized by a XRPD pattern showing absence of diffraction peaks, a FTIR spectrum having peaks at about 2940-1708-1597-1444-1380-1288-1188-1105-1033-959-880-803-678±4 cm −1 and by a Glass Transition (Tg) approximately between 60° C. and 110° C. with a maximum at about 76° C. 3 . The crystalline anhydrous form of claim 1 characterized by a XRPD pattern showing peaks at about 6.0-9.4-11.9-13.2-13.8-15.3-19.1-20.1-24.0-28.1±0.2 degrees two theta, a FTIR pattern with peaks at about 3582-3416-2979-2940-1709-1594-1442-1380-1288-1103-1030-959-881-794-686±4 cm −1 and by a TG/DTA thermogram showing an endothermic signal with maximum at about 100.5° C. and a melting peak with maximum at about 134.4° C. 4 . Solid solvates of ingenol 3-(3,5-diethylisoxazole-4-carboxylate) selected from an acetone solvate, a dimethylcarbonate solvate, an isopropyl ether solvate, an acetonitrile solvate, a toluene solvate, a mesitylene solvate, a nitromethane solvate, a dichloromethane/heptane solvate and an ethyl acetate solvate, for use as intermediates. 5 . The acetone solvate of claim 4 characterized by a XRPD pattern showing peaks at about 5.7-8.5-11.4-12.1-13.1-15.4-19.1-20.6-21.6-24.0±0.2 degrees two theta, by a FTIR pattern with peaks at about 3579-3478-3364-2940-1711-1695-1595-1442-1358-1217-1105-1033-959-880-793-684±4 cm −1 and by a TG/DTA thermogram showing an endothermic signal with maximum at about 123.1° C. associated with a weight loss of about 5% and a melting peak with maximum at about 134.3° C. 6 . The dimethylcarbonate solvate of claim 4 characterized by a XRPD pattern showing peaks at about 5.7-8.4-10.1-11.6-13.0-14.0-15.4-19.3-21.7-23.4±0.2 degrees two theta, by a FTIR pattern with peaks at about 3581-3473-2939-1754-1709-1696-1594-1441-1287-1151-1105-1030-959-880-794-685±4 cm −1 and by a TG/DTA thermogram showing an endothermic signal with maximum at about 137.0° C. associated with a weight loss of about 6-7%. 7 . The isopropyl ether solvate of claim 4 characterized by a XRPD pattern showing peaks at about 5.9-9.2-10.4-11.8-11.9-13.1-13.6-15.1-17.9-22.2-24.1-30.3±0.2 degrees two theta, by a FTIR pattern with peaks at about 3581-3463-2940-1705-1644-1595-1456-1442-1288-1152-1105-1029-959-881-837-794-686±4 cm −1 and by a TG/DTA thermogram showing a weak endothermic signal below 100° C. and an endothermic peak with a maximum at about 135.7° C. associated with a weight loss of about 11.0% at 133° C. 8 . The acetonitrile solvate of claim 4 characterized by FTIR spectrum with peaks at 3581-3474-3378-2940-1706-1644-1596-1456-1312-1288-1152-1104-1076-1049-1030-959-880-794-685±4 cm −1 and by a TG/DTA thermogram showing a weak endothermic signal with maximum at about 124.4° C. associated with a weight loss of about 1.3% at 126° C. 9 . The toluene solvate of claim 4 characterized by a XRPD pattern showing peaks at about 5.6-5.7-8.4-8.5-10.3-11.4-11.5-12.1-13.1-14.1-15.4-19.3-21.6-23.2±0.2 degrees two theta, by a FTIR pattern with peaks at about 3576-3481-2874-1706-1693-1640-1597-1497-1455-1309-1295-1106-1074-1049-1003-958-880-837-794-730-696-684-649±4 cm −1 and by a weak endothermic signal at a maximum at about 123.4 associated with a weight loss of about 8.4% at 129° C. 10 . The nitromethane solvate of claim 4 characterized by a XRPD pattern showing peaks at about 5.8-8.6-9.0-10.4-11.7-13.2-14.1-15.6-21.9-23.6-24.2±0.2 degrees two theta, by a FTIR pattern with peaks at about 3579-3476-2876-1710-1643-1596-1560-1442-1358-1336-1288-1218-1105-1030-959-880-837-794-685±4 cm −1 and by a TG/DTA thermogram showing a double endothermic peak with maxima at about 125.4 and 133.9 associated with a weight loss of about 5.8% at 140° C. 11 . Mesitylene solvate of claim 4 characterized by a XRPD pattern showing peaks at about 5.3-6.0-9.1-10.5-12.1-13.0-14.8-18.2-22.3-24.3-25.8-28.6-30.6-34.7±0.2 degrees two theta, a FTIR spectrum with peaks at about 3580-3479-2876-1705-1642-1595-1560-1455-1441-1381-1311-1288-1150-1105-1074-1029-1003-958-880-836-794-685±4 cm −1 and by a TG/DTA thermogram showing an endothermic peak with maximum at about 133.2° C. associated with a weight loss of about 2.0% at 131° C. 12 . The dichloromethane/heptane solvate of claim 4 characterized by a XRPD pattern showing peaks at about 5.7-8.6-9.0-10.4-11.6-12.2-12.9-14.4-15.5-17.5-19.9-21.7-22.4-28.1-29.4±0.2 degrees two theta, by a FTIR spectrum with peaks at about 3578-3474-2876-1705-1652-1596-1454-1442-1288-1217-1152-1105-1075-1050-1030-1003-958-880-837-794-770-739-700-685±4 cm −1 and by an endothermic signal with maximum at about 130.7° C. associated with a weight loss of about 4.1% between 130 and 135° C. 13 . The ethyl acetate solvate of claim 4 characterized by a XRPD pattern showing peaks at about 5.8-8.6-10.0-11.6-12.7-13.1-14.0-15.6-16.0-19.1-20.2-22.0-23.2±0.2 degrees two theta and by a TG/DTA thermogram showing an endothermic signal with maximum at about 123.8° C. associated with a weight loss of about 5.4% at about 130° C.

Assignees

Inventors

Classifications

  • Crystalline forms, e.g. polymorphs · CPC title

  • C07D261/18Primary

    Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2019210980A1 cover?
Disclosed are solid forms of ingenol 3-(3,5-diethylisoxazole-4-carboxylate) selected from an amorphous form or a crystalline anhydrous form. Also disclosed are solid solvates of ingenol 3-(3,5-diethylisoxazole-4-carboxylate) selected from an acetone solvate, a dimethylcarbonate solvate, an isopropyl ether solvate, an acetonitrile solvate, a toluene solvate, a mesitylene solvate, a nitromethane …
Who is the assignee on this patent?
Indena Spa
What technology area does this patent fall under?
Primary CPC classification C07D261/18. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jul 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).